FDA Warning Letters & 483 Inspections API avatar

FDA Warning Letters & 483 Inspections API

Pricing

from $150.00 / 1,000 compliance actions

Go to Apify Store
FDA Warning Letters & 483 Inspections API

FDA Warning Letters & 483 Inspections API

Joined feed of FDA Warning Letters + Form 483 inspection observations — facility-level severity-scored via FEI join. Pharma QA/QC, CMO/CDMO supplier risk, FDA defense counsel. The compliance-grade feed competitors that ship raw HTML scrapes can't match.

Pricing

from $150.00 / 1,000 compliance actions

Rating

0.0

(0)

Developer

NexGenData

NexGenData

Maintained by Community

Actor stats

0

Bookmarked

2

Total users

1

Monthly active users

5 days ago

Last modified

Categories

Share

📋 FDA Warning Letters + 483 Inspection Observations Tracker

The joined regulatory feed pharma compliance teams actually need. Every Warning Letter and Form 483 the FDA has issued in the last 5 years, mapped to the same facility via FDA Establishment Identifier (FEI), with a per-facility severity score derived from prior actions. Competing Apify actors ship raw HTML scrapes of a single Warning Letters page; this actor ships the joined CMO/CDMO supplier-risk feed that Verisk SteriQual and 3E sell at five figures a year.

The differentiator is the join — match Warning Letters on Pfizer's New Jersey plant to the four Form 483s the same plant has received in the last 18 months, and you get a "recurring" severity tag that drives supplier-risk decisions. Raw HTML scrapers can't do this because they only see one side of FDA's enforcement universe.

🧠 What you get

FieldNotes
typewarning_letter or form_483
dateLetter issue date or Form 483 issuance date (ISO-8601)
manufacturer / facilityCompany Name as published by the FDA
fei_numberFDA Establishment Identifier — canonical facility join key
state, countryFrom the 483 FOIA index (Warning Letters feed has implicit US default)
product_typedrug / device / food / biologic / tobacco / veterinary / any — inferred from FDA Issuing Office (Warning Letters) or Establishment Type (Form 483s)
issuing_officeFull FDA office string for Warning Letters (e.g. "Center for Drug Evaluation and Research (CDER)")
subject / citation_summarySubject line of the Warning Letter, or Form 483 — <establishment-type> inspection
citations[]List of 21 CFR cites parsed from the Warning Letter HTML (e.g. 21 CFR 211.113, 21 CFR 820.30(a)) — Warning Letters only, when the letter URL is resolvable
fdc_act_citations[]FD&C Act section cites (e.g. Section 501(a)(2)(B))
response_deadline_15_working_daysBoolean — whether the letter requires the standard 15-working-day response
fda_divisionThe specific FDA division issuing the letter, when parseable from the HTML
response_letter_received / closeout_letter_issuedBooleans from the Warning Letters feed
full_text_urlDirect link to the FDA's published letter page (or FOIA index for 483s)
establishment_typeFor Form 483s — e.g. "Outsourcing Facility", "Producer of Sterile Drug Products"
facility_severity_score{score, label, prior_warning_letters, prior_form_483s}clean (0 priors), single-prior (1), recurring (2-3), systemic (4+)

🎯 Use cases

  • Pharma QA/QC director — Daily monitoring of CDER Warning Letters against current finished-pharmaceutical CMOs; the severity score surfaces any contractor with a recurring 21 CFR 211.x posture before audit week.
  • CMO/CDMO supplier risk team — Cross-reference every active supplier's FEI against the joined feed; flag any facility with severity_label="recurring" or "systemic" for re-qualification or fallback-sourcing.
  • FDA defense counsel — Pull all Warning Letters + 483s for a client facility, sorted by date, in one CSV — replaces the multi-tab spreadsheet that junior associates spend a day building per matter.
  • Investment due diligence — Pre-IPO/M&A: scan the target's manufacturing footprint against the feed; systemic severity is a Section 8 closing condition issue.
  • Plaintiff law / mass tort intake — Tie individual product complaints (FAERS / MAUDE) to the issuing facility's regulatory posture for proximate-cause arguments.

📊 Sample input

{
"manufacturer_name": "",
"product_type": "drug",
"days_back": 180,
"severity_filter": "both",
"max_records": 50
}

📊 Sample output

{
"type": "warning_letter",
"date": "2026-04-07",
"posted_date": "2026-04-28",
"manufacturer": "Lexia LLC",
"facility": "Lexia LLC",
"state": null,
"country": null,
"fei_number": null,
"product_type": "drug",
"issuing_office": "Center for Drug Evaluation and Research (CDER)",
"subject": "CGMP/Finished Pharmaceuticals/Adulterated",
"citation_summary": "CGMP/Finished Pharmaceuticals/Adulterated",
"citations": ["21 CFR 211.22", "21 CFR 211.100", "21 CFR 211.113"],
"fdc_act_citations": ["section 501(a)(2)(B) of the FD&C Act"],
"response_deadline_15_working_days": true,
"fda_division": "Center for Drug Evaluation and Research (CDER)",
"response_letter_received": false,
"closeout_letter_issued": false,
"full_text_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lexia-llc-...",
"facility_severity_score": {
"score": 2,
"label": "recurring",
"prior_warning_letters": 0,
"prior_form_483s": 2
},
"source": "FDA Warning Letters"
}

And a Form 483 record on the same facility:

{
"type": "form_483",
"date": "2026-04-17",
"publish_date": "2026-05-27",
"manufacturer": "BPI Labs, LLC",
"facility": "BPI Labs, LLC",
"state": "Florida",
"country": "USA",
"fei_number": "3015156709",
"product_type": "drug",
"establishment_type": "Outsourcing Facility",
"record_type": "483",
"observation_count": null,
"severity": "single-prior",
"citation_summary": "Form 483 — Outsourcing Facility inspection",
"full_text_url": "https://www.fda.gov/about-fda/office-regulatory-affairs/ora-foia-electronic-reading-room",
"facility_severity_score": {
"score": 1,
"label": "single-prior",
"prior_warning_letters": 1,
"prior_form_483s": 0
},
"source": "FDA OII FOIA Electronic Reading Room (Form 483 index)"
}

🚀 How to use

Run the actor from the Apify console, or programmatically:

from apify_client import ApifyClient
client = ApifyClient("YOUR_APIFY_TOKEN")
run = client.actor("nexgendata/fda-warning-letters-483-inspections").call(
run_input={
"manufacturer_name": "Intas",
"product_type": "drug",
"days_back": 365,
"severity_filter": "both",
"max_records": 100,
}
)
for item in client.dataset(run["defaultDatasetId"]).iterate_items():
print(item["date"], item["type"], item["manufacturer"],
item["facility_severity_score"]["label"])

cURL:

curl -X POST "https://api.apify.com/v2/acts/nexgendata~fda-warning-letters-483-inspections/runs?token=YOUR_APIFY_TOKEN" \
-H "Content-Type: application/json" \
-d '{"product_type":"drug","days_back":180,"max_records":50}'

⚖️ Compliance & data sources

All sources are published by the U.S. Food and Drug Administration under federal public-disclosure mandate (Federal Food, Drug, and Cosmetic Act § 705, 21 U.S.C. § 375) and are explicitly machine-readable via the XLSX export endpoints:

  • Warning Letters: fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters/datatables-data — covers ~1,000 letters, ~5-year rolling window.
  • Form 483 Inspection Observation Index: fda.gov/about-fda/office-regulatory-affairs/ora-foia-electronic-reading-room/download — OII FOIA Electronic Reading Room export, ~2,000 records, covering 483s + EIRs + closeout reports.

All HTTP requests are sent with the polite-bot User-Agent NexGenData FDA Warning Letters Actor hello@thenextgennexus.com. No anti-bot measures encountered. No FDA rate limits documented for these XLSX endpoints. The actor downloads each XLSX once per run (no per-record requests against FDA).

Future enhancements (paid add-ons under consideration): OCR of the underlying Form 483 PDFs to extract per-observation numbers (currently the FOIA index publishes the count of inspections but not the per-observation cite count from each 483 PDF), HTML enrichment of older Warning Letters whose URLs aren't on the recent-letters HTML index, and a Schedule-A export of the facility severity index alone (for supplier-onboarding KYC use).

ActorWhat it does
⚠️ FDA Recall MonitorDrug + device safety alerts (recalls, withdrawals) — pairs with this actor for full FDA post-market surveillance
Federal Register Rules ScraperDaily federal-register rule publications across all agencies — catches FDA proposed-rules that drive future Warning Letter citations
NIH Reporter Grants ScraperFederal biomedical research funding — counterpart to FDA enforcement for the full healthcare-funding-and-enforcement picture
⚕️ Doctor Directory Lead FinderNPI-registry-backed physician lookups — useful for the pharma-payment + adverse-event analyst stack

🏷️ About NexGenData

NexGenData publishes the deepest set of public-record data actors on Apify — SEC EDGAR forms (NPORT-P, 8-K, Form 4, Form D, 13F, 13D/G, ADV), CISA KEV + EPSS, DOL Form 5500, FDA Warning Letters + 483s + Recalls, FDA Adverse Events (FAERS+MAUDE), FINRA BrokerCheck, EUIPO trademarks, WIPO Patentscope, and more — all priced as pay-per-event so you only pay for the data you actually pull. Visit apify.com/nexgendata for the full catalog.